In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.
about
In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@ast
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@en
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@nl
type
label
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@ast
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@en
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@nl
prefLabel
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@ast
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@en
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@nl
P2093
P2860
P1476
In vivo evaluation of [18F]FEC ...... dioligand in nonhuman primate.
@en
P2093
Akiva Mintz
Harry Rubin-Falcone
J John Mann
J S Dileep Kumar
Jay R Kaplan
Jaya Prabhakaran
Katharine I Tooke
Kiran Kumar Solingapuram Sai
P2860
P356
10.1016/J.BMCL.2016.11.043
P407
P577
2016-11-16T00:00:00Z